Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres

By Rosas J.E.   Pedraz J.L.   Hernandez R.M.   Gascon A.R.   Igartua M.   Guzman F.   Rodrguez R.   Cortes J.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1707-1710

Elsevier

Access to resources Recommend Favorite

The effect of temperature on the stability of the synthetic SPf(66)n malaria vaccine

By Lopez M.C.   Thomas M.C.   Olivares M.   Alonso P.   Alonso C.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1180-1182

Elsevier

Access to resources Recommend Favorite

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

By Kashala O.   Amador R.   Valero M.V.   Moreno A.   Barbosa A.   Nickel B.   Daubenberger C.A.   Guzman F.   Pluschke G.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2263-2277

Elsevier

Access to resources Recommend Favorite

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

By Ying M.   Tamber H.   Audran R.   Gander B.   Corradin G.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1405-1412

Elsevier

Access to resources Recommend Favorite

An efficacy trial of the malaria vaccine SPf66 in Gambian infants-second year of follow-up

By Bojang K.A.   Obaro S.K.   D'Alessandro U.   Bennett S.   Langerock P.   Targett G.A.T.   Greenwood B.M.  

Vaccine, Vol. 16, Iss. 1, 1998-01 ,pp. : 62-67

Elsevier

Access to resources Recommend Favorite